What is Lifecore Biomedical, Inc. Common Stock's Market Cap?

Lifecore Biomedical, Inc. Common Stock's Market Cap is $242.3M, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's Enterprise Value?

Lifecore Biomedical, Inc. Common Stock's Enterprise Value is $416.5M, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's Price / Sales?

Lifecore Biomedical, Inc. Common Stock's Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's EV / Revenue?

Lifecore Biomedical, Inc. Common Stock's EV / Revenue is 3.2×, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's EV / EBITDA?

Lifecore Biomedical, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's Revenue (TTM)?

Lifecore Biomedical, Inc. Common Stock's Revenue (TTM) is $128.9M, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's Net Income (TTM)?

Lifecore Biomedical, Inc. Common Stock's Net Income (TTM) is -$42.0M, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's EBITDA?

Lifecore Biomedical, Inc. Common Stock's EBITDA is -$9.2M, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's Diluted EPS (TTM)?

Lifecore Biomedical, Inc. Common Stock's Diluted EPS (TTM) is -1.11, based on as-reported figures from SEC (XBRL) filings.

What is Lifecore Biomedical, Inc. Common Stock's EBITDA Margin?

Lifecore Biomedical, Inc. Common Stock's EBITDA Margin is -7.2%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Lifecore Biomedical, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S7VTL0

6.40▲ 0.03 (0.47%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 6.37
Day's Range: 6.36 – 6.40
52-Week Range: 3.63 – 9.00
Volume: 221.7K
Avg Volume: 572.7K

Share Statistics

Shares Outstanding
Employees: 382
Exchange: XNAS
Listed: 1996-02-15

Share count as of July 29, 2026

Lifecore Biomedical, Inc. Common Stock (LFCR) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Lifecore Biomedical, Inc. Common Stock (LFCR)

What is Lifecore Biomedical, Inc. Common Stock's Market Cap?: Lifecore Biomedical, Inc. Common Stock's Market Cap is $242.3M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Enterprise Value?: Lifecore Biomedical, Inc. Common Stock's Enterprise Value is $416.5M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Price / Sales?: Lifecore Biomedical, Inc. Common Stock's Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's EV / Revenue?: Lifecore Biomedical, Inc. Common Stock's EV / Revenue is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's EV / EBITDA?: Lifecore Biomedical, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Revenue (TTM)?: Lifecore Biomedical, Inc. Common Stock's Revenue (TTM) is $128.9M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Net Income (TTM)?: Lifecore Biomedical, Inc. Common Stock's Net Income (TTM) is -$42.0M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's EBITDA?: Lifecore Biomedical, Inc. Common Stock's EBITDA is -$9.2M, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's Diluted EPS (TTM)?: Lifecore Biomedical, Inc. Common Stock's Diluted EPS (TTM) is -1.11, based on as-reported figures from SEC (XBRL) filings.
What is Lifecore Biomedical, Inc. Common Stock's EBITDA Margin?: Lifecore Biomedical, Inc. Common Stock's EBITDA Margin is -7.2%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · LFCRAs-filed SEC (XBRL) data